MedTrace Logo

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

NCT00684528 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2012-03-19

No results posted yet for this study

Summary

Comparison between the effectiveness of one anti-diabetic drug (Metformin, To combination of this drug and additional drug (Janufer), In the community setting.

Conditions

  • Diabetes Type 2

Interventions

DRUG

Metformin 1500 mg daily

500 mg thrice daily

DRUG

Metformin + Janufer (Janumet)

Titration up to 1500/150 mg daily

Sponsors & Collaborators

  • Clalit Health Services

    collaborator OTHER

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Joel Zinger, MD · clali health organization

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00684528 on ClinicalTrials.gov